|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2020. CA Cancer J Clin. 70:7–30. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
DeSantis CE, Ma J, Gaudet MM, Newman LA,
Miller KD, Goding Sauer A, Jemal A and Siegel RL: Breast cancer
statistics, 2019. CA Cancer J Clin. 69:438–451. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bishop AJ, Ensor J, Moulder SL, Shaitelman
SF, Edson MA, Whitman GJ, Bishnoi S, Hoffman KE, Stauder MC, Valero
V, et al: Prognosis for patients with metastatic breast cancer who
achieve a no-evidence-of-disease status after systemic or local
therapy. Cancer. 121:4324–4332. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liang Y, Zhang H, Song X and Yang Q:
Metastatic heterogeneity of breast cancer: Molecular mechanism and
potential therapeutic targets. Semin Cancer Biol. 60:14–27. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Schmiedel JM, Klemm SL, Zheng Y, Sahay A,
Blüthgen N, Marks DS and van Oudenaarden A: Gene expression.
MicroRNA control of protein expression noise. Science. 348:128–132.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Loh HY, Norman BP, Lai KS, Rahman N,
Alitheen NBM and Osman MA: The regulatory role of MicroRNAs in
breast cancer. Int J Mol Sci. 20:49402019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fan Y, Shi C, Li T and Kuang T:
microRNA-454 shows anti-angiogenic and anti-metastatic activity in
pancreatic ductal adenocarcinoma by targeting LRP6. Am J Cancer
Res. 7:139–147. 2017.PubMed/NCBI
|
|
10
|
Fan Y, Xu LL, Shi CY, Wei W, Wang DS and
Cai DF: MicroRNA-454 regulates stromal cell derived factor-1 in the
control of the growth of pancreatic ductal adenocarcinoma. Sci Rep.
6:227932016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li W, Feng Y, Ma Z and Lu L: Expression of
miR-454-3p and its effect on proliferation, invasion and metastasis
of colon cancer. Nan Fang Yi Ke Da Xue Xue Bao. 38:1421–1426.
2018.(In Chinese). PubMed/NCBI
|
|
12
|
Sun L, Wang Q, Gao X, Shi D, Mi S and Han
Q: MicroRNA-454 functions as an oncogene by regulating PTEN in
uveal melanoma. FEBS Lett. 589:2791–2796. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bao X, Ren T, Huang Y, Sun K, Wang S, Liu
K, Zheng B and Guo W: Knockdown of long non-coding RNA HOTAIR
increases miR-454-3p by targeting Stat3 and Atg12 to inhibit
chondrosarcoma growth. Cell Death Dis. 8:e26052017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zuo J, Yu H, Xie P, Liu W, Wang K and Ni
H: miR-454-3p exerts tumor-suppressive functions by down-regulation
of NFATc2 in glioblastoma. Gene. 710:233–239. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shao N, Xue L, Wang R, Luo K, Zhi F and
Lan Q: miR-454-3p is an exosomal biomarker and functions as a tumor
suppressor in glioma. Mol Cancer Ther. 18:459–469. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fang B, Zhu J, Wang Y, Geng F and Li G:
MiR-454 inhibited cell proliferation of human glioblastoma cells by
suppressing PDK1 expression. Biomed Pharmacother. 75:148–152. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li Y, Jiao Y, Fu Z, Luo Z, Su J and Li Y:
High miR-454-3p expression predicts poor prognosis in
hepatocellular carcinoma. Cancer Manag Res. 11:2795–2802. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou L, Qu YM, Zhao XM and Yue ZD:
Involvement of miR-454 overexpression in the poor prognosis of
hepatocellular carcinoma. Eur Rev Med Pharmacol Sci. 20:825–829.
2016.PubMed/NCBI
|
|
19
|
Jin C, Lin T and Shan L: Downregulation of
Calbindin 1 by miR-454-3p suppresses cell proliferation in nonsmall
cell lung cancer in vitro. Cancer Biother Radiopharm. 34:119–127.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu S, Ge X, Su L, Zhang A and Mou X:
MicroRNA-454 inhibits nonsmall cell lung cancer cells growth and
metastasis via targeting signal transducer and activator of
transcription-3. Mol Med Rep. 17:3979–3986. 2018.PubMed/NCBI
|
|
21
|
Zhu DY, Li XN, Qi Y, Liu DL, Yang Y, Zhao
J, Zhang CY, Wu K and Zhao S: MiR-454 promotes the progression of
human non-small cell lung cancer and directly targets PTEN. Biomed
Pharmacother. 81:79–85. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cui X, Xiao D, Cui Y and Wang X:
Exosomes-derived long non-coding RNA HOTAIR reduces laryngeal
cancer radiosensitivity by regulating microRNA-454-3p/E2F2 axis.
Onco Targets Ther. 12:10827–10839. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang DY, Li N and Cui YL: Long non-coding
RNA CCAT1 sponges miR-454 to promote chemoresistance of ovarian
cancer cells to cisplatin by regulation of surviving. Cancer Res
Treat. 52:798–814. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fu Q, Gao Y, Yang F, Mao T, Sun Z, Wang H,
Song B and Li X: Suppression of microRNA-454 impedes the
proliferation and invasion of prostate cancer cells by promoting
N-myc downstream-regulated gene 2 and inhibiting WNT/β-catenin
signaling. Biomed Pharmacother. 97:120–127. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huang C, Liu J, Pan X, Peng C, Xiong B,
Feng M and Yang X: miR-454 promotes survival and induces
oxaliplatin resistance in gastric carcinoma cells by targeting
CYLD. Exp Ther Med. 19:3604–3610. 2020.PubMed/NCBI
|
|
26
|
Jiang D, Li H, Xiang H, Gao M, Yin C, Wang
H, Sun Y and Xiong M: Long chain non-coding RNA (lncRNA) HOTAIR
knockdown increases miR-454-3p to suppress gastric cancer growth by
targeting STAT3/Cyclin D1. Med Sci Monit. 25:1537–1548. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xu G, Zhu H, Zhang M and Xu J: Histone
deacetylase 3 is associated with gastric cancer cell growth via the
miR-454-mediated targeting of CHD5. Int J Mol Med. 41:155–163.
2018.PubMed/NCBI
|
|
28
|
Song Z, Li W, Wang L, Jia N and Chen B:
MicroRNA-454 inhibits tumor cell proliferation, migration and
invasion by downregulating zinc finger Eboxbinding homeobox 1 in
gastric cancer. Mol Med Rep. 16:9067–9073. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Song Y, Guo Q, Gao S and Hua K: miR-454-3p
promotes proliferation and induces apoptosis in human cervical
cancer cells by targeting TRIM3. Biochem Biophys Res Commun.
516:872–879. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang S, Zhang G, Zheng W, Xue Q, Wei D,
Zheng Y and Yuan J: MiR-454-3p and miR-374b-5p suppress migration
and invasion of bladder cancer cells through targetting ZEB2.
Biosci Rep. 38:BSR201814362018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Guo JY, Wang YK, Lv B and Jin H: miR-454
performs tumor-promoting effects in oral squamous cell carcinoma
via reducing NR3C2. J Oral Pathol Med. 49:286–293. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Niu G, Li B, Sun J and Sun L: miR-454 is
down-regulated in osteosarcomas and suppresses cell proliferation
and invasion by directly targeting c-Met. Cell Prolif. 48:348–355.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wu X, Ding N, Hu W, He J, Xu S, Pei H, Hua
J, Zhou G and Wang J: Down-regulation of BTG1 by miR-454-3p
enhances cellular radiosensitivity in renal carcinoma cells. Radiat
Oncol. 9:1792014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li X, Hou L, Yin L and Zhao S: LncRNA XIST
interacts with miR-454 to inhibit cells proliferation, epithelial
mesenchymal transition and induces apoptosis in triple-negative
breast cancer. J Biosci. 45:452020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ren L, Chen H, Song J, Chen X, Lin C,
Zhang X, Hou N, Pan J, Zhou Z, Wang L, et al: MiR-454-3p-mediated
Wnt/β-catenin signaling antagonists suppression promotes breast
cancer metastasis. Theranostics. 9:449–465. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li Q, Liu J, Meng X, Pang R and Li J:
MicroRNA-454 may function as an oncogene via targeting AKT in
triple negative breast cancer. J Biol Res (Thessalon). 24:102017.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Rastaldi MP: Epithelial-mesenchymal
transition and its implications for the development of renal
tubulointerstitial fibrosis. J Nephrol. 19:407–412. 2006.PubMed/NCBI
|
|
39
|
Dongre A and Weinberg RA: New insights
into the mechanisms of epithelial-mesenchymal transition and
implications for cancer. Nat Rev Mol Cell Biol. 20:69–84. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ding L, Gu H, Xiong X, Ao H, Cao J, Lin W,
Yu M, Lin J and Cui Q: MicroRNAs involved in carcinogenesis,
prognosis, therapeutic resistance and applications in human
triple-negative breast cancer. Cells. 8:14922019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Petri BJ and Klinge CM: Regulation of
breast cancer metastasis signaling by miRNAs. Cancer Metastasis
Rev. 39:837–886. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yang Q, Cao X, Tao G, Zhou F, Zhao P, Shen
Y and Chen X: Effects of FOXJ2 on TGF-β1-induced
epithelial-mesenchymal transition through Notch signaling pathway
in non-small lung cancer. Cell Biol Int. 41:79–83. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Qiang Y, Wang F, Yan S, Zhang H, Zhu L and
Chen Z, Tu F, Wang D, Wang G, Wang W and Chen Z: Abnormal
expression of Forkhead Box J2 (FOXJ2) suppresses migration and
invasion in extrahepatic cholangiocarcinoma and is associated with
prognosis. Int J Oncol. 46:2449–2458. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Qiu X, Ji B, Yang L, Huang Q, Shi W, Ding
Z, He X, Ban N, Fan S, Zhang J and Tian Y: The role of FoxJ2 in the
migration of human glioma cells. Pathol Res Pract. 211:389–397.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wang Y, Yang S, Ni Q, He S, Zhao Y, Yuan
Q, Li C, Chen H, Zhang L, Zou L, et al: Overexpression of forkhead
box J2 can decrease the migration of breast cancer cells. J Cell
Biochem. 113:2729–2737. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Lee C and Huang CH: LASAGNA-Search 2.0:
Integrated transcription factor binding site search and
visualization in a browser. Bioinformatics. 30:1923–1925. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Crudele F, Bianchi N, Reali E, Galasso M,
Agnoletto C and Volinia S: The network of non-coding RNAs and their
molecular targets in breast cancer. Mol Cancer. 19:612020.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Cao ZG, Li JJ, Yao L, Huang YN, Liu YR, Hu
X, Song CG and Shao ZM: High expression of microRNA-454 is
associated with poor prognosis in triple-negative breast cancer.
Oncotarget. 7:64900–64909. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Jin Y, Liang Z and Lou H: The emerging
roles of fox family transcription factors in chromosome
replication, organization, and genome stability. Cells. 9:2582020.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kehn K, Berro R, Alhaj A, Bottazzi ME, Yeh
WI, Klase Z, Van Duyne R, Fu S and Kashanchi F: Functional
consequences of cyclin D1/BRCA1 interaction in breast cancer cells.
Oncogene. 26:5060–5069. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Qiang Y, Feng L, Wang G, Liu J, Zhang J,
Xiang L, Su C, Zhang S, Xie X and Chen E: miR-20a/Foxj2 axis
mediates growth and metastasis of colorectal cancer cells as
identified by integrated analysis. Med Sci Monit. 26:e9235592020.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zhang H, Tang QF, Sun MY, Zhang CY, Zhu
JY, Shen YL, Zhao B, Shao ZY, Zhang LJ and Zhang H: ARHGAP9
suppresses the migration and invasion of hepatocellular carcinoma
cells through up-regulating FOXJ2/E-cadherin. Cell Death Dis.
9:9162018. View Article : Google Scholar : PubMed/NCBI
|
